KCT0006626尚未招募未知
Randomized, double-blinded, multi-center, prospective clinical trial for therapeutic efficacy of home-based long-term cerebellar transcranial direct current stimulation on cerebellar ataxia
Bundang CHA General Hospital0 个研究点目标入组 46 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 30?(Year) 至 70?(Year)（—）
- 性别
- All
入选标准
- •1. Age ranging from 30 to 69 years old
- •2. Patients with cerebellar ataxia, diagnosed as multisystem atrophy-cerebellar type, spinocerebellar ataxia, idiopathic late onset cerebellar ataxia
- •3. K-MMSE >=24
- •4. Unassisted gait (for more than 10 m)
- •5. Voluntarily signed up for the clinical trial
排除标准
- •1. Presence of medical or neurological disorders, or head trauma history
- •2. Presence of cognitive dysfunction affecting the ability to understand informed consent or perform the clinical trial
- •3. Presence of any suicidal idea or psychiatric disorders
- •4. Contraindication for tDCS (e.g. metallic device inserted in head)
- •5. Presence of skin problem hindering electrode adherence
- •6. Possibility of pregnancy
- •7. Pregnant state
- •8. Other reasons that are considered unsuitable for study enrollment
研究者
相似试验
进行中（未招募）
1 期
A clinical study to compare the efficacy and safety of macitentan and tadalafil monotherapies with the corresponding fixed dose combination in subjects with pulmonary arterial hypertension (PAH).Pulmonary Arterial HypertensionMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-004786-25-BGActelion Pharmaceuticals Ltd.250
进行中（未招募）
1 期
Clinical study assessing the safety and efficacy of macitentan in Fontan-palliated subjects.Congenital Heart FailureEUCTR2016-003320-23-FRActelion Pharmaceuticals Ltd134
进行中（未招募）
1 期
Clinical study assessing the safety and efficacy of macitentan in Fontan-palliated subjects.Congenital Heart FailureEUCTR2016-003320-23-CZActelion Pharmaceuticals Ltd134
进行中（未招募）
1 期
Clinical study assessing the safety and efficacy of macitentan in Fontan-palliated subjects.EUCTR2016-003320-23-IEActelion Pharmaceuticals Ltd134
进行中（未招募）
1 期
A clinical study to compare the efficacy and safety of macitentan and tadalafil monotherapies with the corresponding fixed dose combination in subjects with pulmonary arterial hypertension (PAH).Pulmonary Arterial HypertensionMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-004786-25-DEActelion Pharmaceuticals Ltd.250